Assessing absolute stroke risk in patients with atrial fibrillation using a risk factor-based approach
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Assessing absolute stroke risk in patients with atrial fibrillation using a risk factor-based approach. / Lee, Christina J-Y; Toft-Petersen, Anne Pernille; Ozenne, Brice; Phelps, Matthew; Olesen, Jonas Bjerring; Ellinor, Patrick T.; Gislason, Gunnar; Lip, Gregory Y. H.; Torp-Pedersen, Christian; Gerds, Thomas Alexander.
In: European Heart Journal - Cardiovascular Pharmacotherapy, Vol. 7, No. F11, 2021, p. F3-F10.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Assessing absolute stroke risk in patients with atrial fibrillation using a risk factor-based approach
AU - Lee, Christina J-Y
AU - Toft-Petersen, Anne Pernille
AU - Ozenne, Brice
AU - Phelps, Matthew
AU - Olesen, Jonas Bjerring
AU - Ellinor, Patrick T.
AU - Gislason, Gunnar
AU - Lip, Gregory Y. H.
AU - Torp-Pedersen, Christian
AU - Gerds, Thomas Alexander
PY - 2021
Y1 - 2021
N2 - Aim To assess the risk of stroke and thromboembolism in patients with atrial fibrillation (AF) based on risk factor com- binations of the CHA(2)DS(2)-VASc score.Methods and results Using nationwide Danish registries, patients with AF were included from 1997 to 2015 in this retrospective observational study. A multiple logistic regression, including interactions of history of stroke with age at AF, calendar year of AF, and the CHA(2)DS(2)-VASc score risk factors (congestive heart failure, hypertension, diabetes, vascular disease, and female sex) were used to predict the personalized risks of stroke within 1 year. A total of 147 842 patients with AF were included in the study cohort (median age 76 years, range 20-100 years, 51% females). Within the first year, 6% of the cohort were diagnosed with stroke. The predicted personalized 1-year absolute risk of stroke varied widely within each CHA(2)DS(2)-VASc score. To estimate the personalized risk of stroke an online calculator was created, the Calculator of Absolute Stroke Risk (CARS), which allows calculation of all the possible combinations of the CHA(2)DS(2)-VASc score (https://hjerteforeningen.shinyapps.io/riskvisrr/).Conclusion Calculation of the individual risk using a risk factor-based approach as opposed to using average risk for a particular CHA(2)DS(2)-VASc score can improve risk estimates. Furthermore, CARS can assist in the communication of the stroke risk for a more evidence-based shared decision-making of whether to initiate oral anticoagulation therapy.
AB - Aim To assess the risk of stroke and thromboembolism in patients with atrial fibrillation (AF) based on risk factor com- binations of the CHA(2)DS(2)-VASc score.Methods and results Using nationwide Danish registries, patients with AF were included from 1997 to 2015 in this retrospective observational study. A multiple logistic regression, including interactions of history of stroke with age at AF, calendar year of AF, and the CHA(2)DS(2)-VASc score risk factors (congestive heart failure, hypertension, diabetes, vascular disease, and female sex) were used to predict the personalized risks of stroke within 1 year. A total of 147 842 patients with AF were included in the study cohort (median age 76 years, range 20-100 years, 51% females). Within the first year, 6% of the cohort were diagnosed with stroke. The predicted personalized 1-year absolute risk of stroke varied widely within each CHA(2)DS(2)-VASc score. To estimate the personalized risk of stroke an online calculator was created, the Calculator of Absolute Stroke Risk (CARS), which allows calculation of all the possible combinations of the CHA(2)DS(2)-VASc score (https://hjerteforeningen.shinyapps.io/riskvisrr/).Conclusion Calculation of the individual risk using a risk factor-based approach as opposed to using average risk for a particular CHA(2)DS(2)-VASc score can improve risk estimates. Furthermore, CARS can assist in the communication of the stroke risk for a more evidence-based shared decision-making of whether to initiate oral anticoagulation therapy.
KW - Atrial fibrillation
KW - Anticoagulation therapy
KW - CHA(2)DS(2)-VASC score
KW - Personalized risk
KW - Stroke
KW - Thromboembolism
KW - NATIONAL REGISTRY
KW - FEMALE SEX
KW - VALIDITY
KW - GENDER
KW - MODELS
KW - HEALTH
KW - SCORE
U2 - 10.1093/ehjcvp/pvaa063
DO - 10.1093/ehjcvp/pvaa063
M3 - Journal article
C2 - 32531029
VL - 7
SP - F3-F10
JO - European Heart Journal - Cardiovascular Pharmacotherapy
JF - European Heart Journal - Cardiovascular Pharmacotherapy
SN - 2055-6837
IS - F11
ER -
ID: 270542878